Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2013
10/30/2013EP2655355A1 New triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
10/30/2013EP2655347A1 Triazine derivatives for electronic applications
10/30/2013EP2655340A1 Bi-heteroaryl compounds as vps34 inhibitors
10/30/2013EP2655339A1 Electronic device including a pyrimidine compound
10/30/2013EP2655331A1 Glucagon receptor modulators
10/30/2013EP2655330A1 Substituted pyridines as sodium channel blockers
10/30/2013EP2655326A1 4- (hetero) aryl - ethynyl - octahydro - indole - 1 - carboxylic acid esters
10/30/2013EP2655323A1 Ingenol-3-acylates iii and ingenol-3-carbamates
10/30/2013EP2655322A1 Process for preparing chiral amino acids
10/30/2013EP2654751A1 Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof
10/30/2013EP2654748A1 Indazole derivatives useful as erk inhibitors
10/30/2013EP2654425A2 Ectoparasiticidal active substance combinations
10/30/2013CN103380133A Compounds and their use as BACE inhibitors
10/30/2013CN103380132A Phenanthridine macrocyclic hepatitis c serine protease inhibitors
10/30/2013CN103380124A Fungicide hydroximoyl-tetrazole derivatives
10/30/2013CN103380118A Tau成像探针 Tau imaging probe
10/30/2013CN103380117A Picolinamide inhibitors of kinases
10/30/2013CN103373986A Crizotinib prodrug, as well as preparation and application thereof
10/30/2013CN103373985A 杂环化合物及其用途 Heterocyclic compounds and their use
10/30/2013CN103373984A Hydrindene amide compound crystal form, preparation method and usage thereof
10/30/2013CN103373966A 4-anilino quinazoline amido derivatives as well as preparation methods and applications thereof
10/30/2013CN103373955A Multivalent azasugar derivatives and synthetic method thereof
10/30/2013CN102633774B Methionine or oxidized methionine modified Clinafloxacin and application thereof
10/30/2013CN102603714B Method for synthesizing sulfinyl compound with single optical-configuration
10/30/2013CN102372695B Compound containing aryl pyridine rings, and application thereof
10/30/2013CN102344440B Anticoccidial compound for livestock and poultry and preparation method thereof
10/30/2013CN102219745B 2-aryl substituted benzimidazole derivatives, as well as preparation method and application thereof
10/30/2013CN102108078B 1,4-substituted phthalazine compound and preparation method and applications thereof
10/30/2013CN102066360B Quinoline or isoquinoline substituted P2X7 antagonists
10/30/2013CN101679358B Pyrrole derivatives as p2y12 antagonists
10/30/2013CN101432275B Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
10/30/2013CN101084215B Piperidine and azetidine derivatives as GLYT1 inhibitors
10/29/2013US8569511 Substituted 3-(1H-benzo[d]imidazol-2-yl)-1H-indazole analogs as inhibitors of the PDK1 kinase
10/29/2013US8569509 Thiazole-4-carboxylic acid esters and thioesters as plant protection agents
10/29/2013US8569492 Method for preparing halofuginone derivative
10/29/2013US8569485 Phenyl-substituted 1,3,5-triazine compound, process for producing the same, and organic electroluminescent device containing the same as component
10/29/2013US8569340 AMPK-activating piperidinyloxypyiridine carboxamide and sulfonamide compounds and methods for using the same
10/29/2013US8569339 Soluble guanylate cyclase activators
10/29/2013US8569323 Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereof
10/29/2013US8569319 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
10/29/2013US8569317 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
10/29/2013US8569311 Pyridyl piperidine orexin receptor antagonists
10/29/2013US8569310 Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions and their use
10/29/2013US8569306 JNK modulators
10/29/2013US8569299 Prolylcarboxypeptidase inhibitors
10/29/2013US8569298 Pyridine compounds
10/29/2013US8569297 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
10/29/2013US8569287 Azepino[4,5-B]indoles and methods of use
10/29/2013US8569286 Notch pathway signaling inhibitor compound
10/29/2013US8569281 Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK
10/29/2013CA2606682C 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
10/29/2013CA2563038C Neurologically-active compounds
10/24/2013WO2013158952A1 Isoindolone derivatives
10/24/2013WO2013158874A1 Methods of producing anamorelin hydrochloride having controlled chloride content
10/24/2013WO2013158422A1 Heterocyclic compounds for controlling invertebrate pests
10/24/2013WO2013157886A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/24/2013WO2013157622A1 Hiv replication inhibitor
10/24/2013WO2013157540A1 Nitrogen-containing heterocyclic compound or salt thereof
10/24/2013WO2013157511A1 Arylaminopyrazole derivative
10/24/2013WO2013157495A1 Organic electroluminescence element and production method for organic electroluminescence element
10/24/2013WO2013156608A1 Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
10/24/2013WO2013135671A9 Fungicidal pyrimidine compounds
10/24/2013WO2012141554A8 Complex in which anti-cotinine antibody is bound to conjugate of cotinine and binding substance, and use thereof
10/24/2013US20130281704 Salts of benzimidazole compound and use thereof
10/24/2013US20130281701 Crystal forms of anamorelin
10/24/2013US20130281488 Maleate salts of (e)-n--4-(dimethylamino)-2-butenamide and crystalline forms thereof
10/24/2013US20130281485 Bridged bicyclic rho kinase inhibitor compounds, compositions and use
10/24/2013US20130281476 Modulators of Muscarinic Receptors
10/24/2013US20130281465 Pyrazole derivative
10/24/2013US20130281455 Phenylpyri(mi)dinylazoles
10/24/2013US20130281451 Indolin-2-one derivatives as protein kinase inhibitors
10/24/2013US20130281450 Isoindolone derivatives
10/24/2013US20130281443 Inhibitors of focal adhesion kinase
10/24/2013US20130281432 Pyridinones/pyrazinones, method of making, and method of use thereof
10/24/2013US20130281430 Amino-Indolyl-Substituted Imidazolyl-Pyrimidines and Their Use as Medicaments
10/24/2013US20130281429 2,4-diamino-pyrimidines as aurora inhibitors
10/24/2013US20130281428 Pyridone Derivatives
10/24/2013US20130281426 Pyridazinones, the preparation method and the use thereof
10/24/2013US20130281399 Treatment of diseases by epigenetic regulation
10/24/2013US20130281398 Treatment of diseases by epigenetic regulation
10/24/2013US20130280305 Cationic lipid
10/24/2013US20130280211 Hepatitis C Virus Inhibitors
10/23/2013EP2653469A1 Pyrazole derivative
10/23/2013EP2653468A1 Bicyclic Compound and Use Thereof for Medical Purposes
10/23/2013EP2651927A1 Anti-viral compounds
10/23/2013EP2651925A2 Anti-viral compounds
10/23/2013EP2651923A1 Anti-viral compounds
10/23/2013EP2651920A2 Anti-viral compounds
10/23/2013EP2651919A1 Dimeric iap inhibitors
10/23/2013EP2651918A1 Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine
10/23/2013EP2651917A1 Dimeric iap inhibitors
10/23/2013EP2651916A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21
10/23/2013EP2651915A1 Continuous arycyclic compound
10/23/2013EP2651905A2 Metalloenzyme inhibitor compounds
10/23/2013EP2651899A2 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
10/23/2013EP2651898A1 Novel n- (4- (azetidine - 1 - carbonyl) phenyl) - (hetero - ) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
10/23/2013EP2651890A1 Strigolactam derivatives and their use as plant growth regulators
10/23/2013EP2651889A1 4-aminoindole derivatives and use thereof for the oxidation dyeing of keratin fibres
10/23/2013CN103360368A Organic semiconductor material containing benzimidazole substituted pyridine as well as preparation method and applications thereof
10/23/2013CN103360367A Chiral amine derived from proline and preparation method
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 1080